Genetics Generation Advancement Corp operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genetics Generation Advancement Corp with three other
pharmaceutical manufacturers in Asia:
Biotoxtech Company Limited
of KOREA (SOUTH)
sales of 26.43 billion Korean Won [US$23.63 million]
CellSource Co Ltd
(1.86 billion Japanese Yen [US$16.85 million]
of which 91%
was Regenerative Medicine Related Business), and
Suzhou Basecare Medical Corp Ltd
based in HONG KONG
(91.37 million Hong Kong Dollars [US$11.77 million]
During the first
quarter of 2021, sales at Genetics Generation Advancement Corp totalled
120.21 million Taiwanese Dollars .
an increase of 13.5%
from the 105.95 million Taiwanese Dollars in sales at the company during the first quarter of 2020.
Genetics Generation Advancement Corp reported sales of 443.13 million Taiwanese Dollars (US$16.02 million)
December of 2020.
increase of 3.2%
versus 2019, when the company's sales were 429.38 million Taiwanese Dollars .
Sales at Genetics Generation Advancement Corp have increased during each of the previous five years
(and since 2015, sales have increased a total of 61%).